Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [9648]

Sacituzumab govitecan plus pembrolizumab improves outcomes beyond progression...

Dr Kevin Kalinsky - Winship Cancer Institute, Atlanta, USA

Sacituzumab govitecan plus pembrolizumab improves outcomes beyond progression in PD-L1-positive mTNBC ( Dr Kevin Kalinsky - Winship Cancer Institute, Atlanta, USA )

ASCO 2026: Latest video and news updates - click here

ASCO 2026: Latest video and news updates - click here ( )

Personalised mRNA vaccine plus pembrolizumab shows durable benefit in high-risk...

Dr Matteo S. Carlino - Westmead Hospital and Melanoma Institute Australia...

Personalised mRNA vaccine plus pembrolizumab shows durable benefit in high-risk melanoma ( Dr Matteo S. Carlino - Westmead Hospital and Melanoma Institute Australia, Sydney, Australia )

ASCO 2026: Highlights and analysis

Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada

ASCO 2026: Highlights and analysis ( Assoc Prof Bishal Gyawali - Queen's University, Kingston, Canada )

Velzatinib demonstrates broad activity across KIT mutations in advanced...

Dr Neeta Somaiah - The University of Texas MD Anderson Cancer Center, Houston...

Velzatinib demonstrates broad activity across KIT mutations in advanced gastrointestinal stromal tumours ( Dr Neeta Somaiah - The University of Texas MD Anderson Cancer Center, Houston, USA )

Optimal panitumumab–bevacizumab sequencing evaluated in RAS wild-type...

Dr Ramón Salazar - The University of Barcelona, Barcelona, Spain

Optimal panitumumab–bevacizumab sequencing evaluated in RAS wild-type metastatic colorectal cancer ( Dr Ramón Salazar - The University of Barcelona, Barcelona, Spain )

Bupropion shows benefit for cancer-related fatigue in cancer survivors

Dr Luke Joseph Peppone - University of Rochester Medical Center, Rochester, USA

Bupropion shows benefit for cancer-related fatigue in cancer survivors ( Dr Luke Joseph Peppone - University of Rochester Medical Center, Rochester, USA )

Relacorilant chemo combination extends OS in platinum-resistant ovarian cancer

Dr Lucy Gilbert - McGill University Health Centre, Montreal, Canada

Relacorilant chemo combination extends OS in platinum-resistant ovarian cancer ( Dr Lucy Gilbert - McGill University Health Centre, Montreal, Canada )

Aspirin in stage III colorectal cancer shows no significant DFS benefit but...

Dr Atsuo Takashima - National Cancer Center Hospital, Tokyo, Japan

Aspirin in stage III colorectal cancer shows no significant DFS benefit but favourable safety ( Dr Atsuo Takashima - National Cancer Center Hospital, Tokyo, Japan )

Short-term fasting linked to improved chemo response in advanced ovarian cancer

Dr Claudia Marchetti - Policlinico Universitario Agostino Gemelli, Rome, Italy

Short-term fasting linked to improved chemo response in advanced ovarian cancer ( Dr Claudia Marchetti - Policlinico Universitario Agostino Gemelli, Rome, Italy )

FMISO PET-guided radiation dose de-escalation maintains long-term outcomes in...

Dr Nancy Y. Lee - Memorial Sloan Kettering, New York, USA

FMISO PET-guided radiation dose de-escalation maintains long-term outcomes in HPV-associated oropharyngeal cancer ( Dr Nancy Y. Lee - Memorial Sloan Kettering, New York, USA )

ASCO 2026: Latest in prostate cancer

Prof Eleni Efstathiou, Prof Boris Hadaschik, Dr Mary-Ellen Taplin and Prof Axel...

ASCO 2026: Latest in prostate cancer ( Prof Eleni Efstathiou, Prof Boris Hadaschik, Dr Mary-Ellen Taplin and Prof Axel Merseburger )

More from ecancer